Mark Cuban Cost Plus Drug Company, PBC · 13 hours ago
Sales Account Manager
Dallas, TX
Full-time
Onsite
Mid Level
3+ years expMark Cuban Cost Plus Drug Company, PBC is seeking a Sales Account Manager to lead account development and penetration strategies for assigned customers or regions. The ideal candidate will be responsible for managing a portfolio of accounts, building and maintaining client relationships, and executing strategic account plans.
Health CareMedicalPharmaceuticalWellnessWholesale
Responsibilities
Manage a portfolio of accounts
Develop positive relationship with clients
Resolve conflicts and provide solutions to clients in a timely manner
Serve as the primary liaison for assigned hospital and health system accounts
Develop and execute strategic account plans with clear sales and growth objectives
Build and strengthen relationships with Pharmacy Directors, procurement, and decision-makers
Manage the full sales cycle, prospecting to contract through both in-person and virtual engagement
Analyze pharmacy needs and market trends to uncover upsell/cross-sell opportunities
Collaborate with internal teams: product, operations, marketing, compliance, and finance
Maintain accurate CRM and performance reporting dashboards
Position MCCPDC's 503B portfolio effectively and stay current with industry developments
Represent MCCPDC at customer-facing events and conferences (up to 30% travel anticipated)
Qualification
Required
Bachelor's degree (or equivalent) in life sciences, business, or related field
Minimum 3 years of B2B pharmaceutical/medical/503B sales experience—preferably within hospital settings
Proven track record with hospital system or formulary decision-makers
Strong oral and written communication skills, including sales presentations and negotiations
Analytical mindset with proficiency in Excel and CRM platforms (e.g., Salesforce)
Highly motivated, self-driven, and adept at building strategic client relationships
Company
Mark Cuban Cost Plus Drug Company, PBC
We’re making and selling medicines at fixed, transparent profit margins to provide an affordable option for patients left behind by market and regulatory forces.
2-10 employees
Funding
Current Stage
Early StageLeadership Team
Alexander Oshmyanksy
CEO / Co-Founder
Recent News
2025-12-05
MarketScreener
2025-12-05
Company data provided by crunchbase